Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.

作者: Lei Zhou , WeiWei Sheng , Chao Jia , Xiaoyang Shi , Rongxian Cao

DOI: 10.1111/JCMM.15676

关键词:

摘要: Our previous studies found overexpression of Musashi2 (MSI2) conduced to the progression and chemoresistance pancreatic cancer (PC) by negative regulation Numb wild type p53 (wtp53). Now, we further investigated novel signalling involved with MSI2 in PC. We identified inositol-3-phosphate synthase 1 (ISYNA1) as a tumour suppressor regulated MSI2. High low ISYNA1 expression were prevalently observed 91 PC tissues. was negatively correlated expression, T stage, vascular permeation poor prognosis patients. What's more, patients expressed high level had significant worse prognosis. And wtp53 Capan-2 SW1990 cells, downregulated silencing. silencing promoted cell proliferation cycle inhibiting p21 enhanced migration invasion upregulating ZEB-1. However, upregulated but ZEB-1, which can be rescued Moreover, reduction resulting from significantly reversed In summary, facilitates development through ISYNA1-p21/ZEB-1 pathway, provides new gene target therapy for

参考文章(30)
Marine L. Croze, Christophe O. Soulage, Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. ,vol. 95, pp. 1811- 1827 ,(2013) , 10.1016/J.BIOCHI.2013.05.011
A Azimi, M Pernemalm, M Frostvik Stolt, J Hansson, J Lehtiö, S Egyházi Brage, C Hertzman Johansson, Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance British Journal of Cancer. ,vol. 110, pp. 2489- 2495 ,(2014) , 10.1038/BJC.2014.169
Chang Ohk Sung, Song Yiang Han, Seok-Hyung Kim, Low Expression of Claudin-4 is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma Annals of Surgical Oncology. ,vol. 18, pp. 273- 281 ,(2011) , 10.1245/S10434-010-1289-4
Ryouta MAEBA, Hiroshi HARA, Hiroshi ISHIKAWA, Shigeru HAYASHI, Nakayuki YOSHIMURA, Jyun KUSANO, Yoko TAKEOKA, Daijiro YASUDA, Tomoki OKAZAKI, Makoto KINOSHITA, Tamio TERAMOTO, Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome. Journal of Nutritional Science and Vitaminology. ,vol. 54, pp. 196- 202 ,(2008) , 10.3177/JNSV.54.196
Ratnam S Seelan, M Michele Pisano, Robert M Greene, Manuel F Casanova, Ranga N Parthasarathy, Differential methylation of the gene encoding myo-inositol 3-phosphate synthase (Isyna1) in rat tissues Epigenomics. ,vol. 3, pp. 111- 124 ,(2011) , 10.2217/EPI.10.73
Amar B Singh, Ashok Sharma, J Joshua Smith, Moorthy Krishnan, Xi Chen, Steven Eschrich, Mary K Washington, Timothy J Yeatman, R Daniel Beauchamp, Punita Dhawan, Claudin-1 Up-regulates the Repressor ZEB-1 to Inhibit E-Cadherin Expression in Colon Cancer Cells Gastroenterology. ,vol. 141, pp. 2140- 2153 ,(2011) , 10.1053/J.GASTRO.2011.08.038
Lu He, Xinke Zhou, Chen Qu, Lijuan Hu, Yunqiang Tang, Qiong Zhang, Min Liang, Jian Hong, Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition Journal of Cellular and Molecular Medicine. ,vol. 18, pp. 49- 58 ,(2014) , 10.1111/JCMM.12158
K Aigner, B Dampier, L Descovich, M Mikula, A Sultan, M Schreiber, W Mikulits, T Brabletz, D Strand, P Obrist, W Sommergruber, N Schweifer, A Wernitznig, H Beug, R Foisner, A Eger, The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity Oncogene. ,vol. 26, pp. 6979- 6988 ,(2007) , 10.1038/SJ.ONC.1210508